Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro [Phase 2]
A Phase 2 study evaluated two dose strengths of TI Inhalation Powder (Technosphere insulin) in adults with Type 1 diabetes and compared a 30…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks [Phase 3]
Phase 3 trial evaluating the safety and efficacy of Technosphere Insulin Inhalation Powder with Lantus, compared to Humalog and Lantus, over…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes [Phase 3]
Phase 3 trial safety results for inhaled insulin in adults with Type 1 and Type 2 diabetes are reported. The study is completed, with result…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Recurrent Hypoglycaemia in Type 1 Diabetes [NA]
A clinical trial investigating recurrent hypoglycaemia in individuals with Type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: A Study in Adults With Type 1 Diabetes [Phase 3]
A Phase 3 clinical trial in adults with Type 1 diabetes has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus [Phase 1]
Phase 1 trial comparing LY2963016 with Lantus (insulin glargine) after a single dose in people with type 1 diabetes; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial update evaluating insulin glulisine and insulin aspart for postprandial glycemic control after a high-glycemic meal i…
-
FDA approval · 2014-09-30FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (Italy) [NA]
Status update on Early Feasibility Study 2 in Italy evaluating the efficacy of the Outpatient Control-to-Range testing system for Type 1 dia…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase [Phase 4]
Phase 4 randomized, double-blind crossover study evaluating recombinant hyaluronidase pretreatment in two-way CSII treatment for Type 1 Diab…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes
The University of Virginia-sponsored clinical trial evaluating the impact of fitness on vascular dysfunction in adolescents with Type 1 diab…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.
This trial update reports on using PET imaging with the radiolabeled tracer [11C] dihydrotetrabenazine (DTBZ) to estimate pancreatic beta ce…
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: Influence of Diabetes on Tramadol Pharmacokinetics [Phase 4]
Phase 4 trial evaluating how diabetes status influences tramadol pharmacokinetics in patients with neuropathic pain.
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Physiologic Response to Glucagon at Varying Insulin Levels [NA]
A completed clinical trial investigated how glucagon’s physiological response changes with different insulin levels in people with type 1 di…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Artificial Pancreas Control System in an Inpatient Setting [Phase 2]
Phase 2 trial update for an inpatient artificial pancreas control system in Type 1 diabetes mellitus. The study status is completed, with re…
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Safety and Efficacy of Overnight Closed Loop in Children With Type 1Diabetes Mellitus in Luxembourg [NA]
A completed clinical trial assessed the safety and efficacy of an overnight closed-loop insulin delivery system in children with Type 1 diab…
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: The Multi-Sensor Distance Accuracy Study
The Multi-Sensor Distance Accuracy Study sponsored by Oregon Health and Science University has completed, with Type 1 Diabetes Mellitus as t…
-
CLINICAL_TRIALS withdrawal · 2014-09-16Clinical Trial Update: Islet After Kidney Transplant for Type 1 Diabetes [Phase 1, Phase 2]
A clinical trial update notes that the Phase 1/2 Islet After Kidney Transplant for Type 1 Diabetes trial has been withdrawn.
-
FDA approval · 2014-09-12FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2014-09-12FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2014-09-12FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company, with the submission involving a diluent component.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Naltrexone and Hypoglycemia in Type 1 Diabetes [Phase 1, Phase 2]
Clinical trial update on naltrexone for hypoglycemia in Type 1 diabetes, completed with results posted in 2014 (Phases 1 and 2).
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Improving Control and Reducing the Risk of Hypoglycemic Episodes in Type 1 Diabetes [NA]
A completed clinical trial reported results aimed at improving glycemic control and reducing hypoglycemic episodes in people with type 1 dia…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy [NA]
Early Feasibility Study 2 of an outpatient control-to-range testing system for Type 1 diabetes has completed, and results have been posted. …
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients [Phase 1, Phase 2]
A Phase 1/2 trial evaluating PEG-encapsulated islet allografts for type 1 diabetes was terminated, with the update addressing safety and eff…